首页 | 本学科首页   官方微博 | 高级检索  
     


Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study.
Authors:J Ferguson   K J MacDonald     K J Kenicer
Abstract:
Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial. An oral twice daily 60 mg dose of terfenadine was given and itch and wheal parameters were assessed daily. Despite the overall effectiveness of terfenadine, a variable response was noted which was similar to that shown in previous studies with other antihistamines.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号